Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$50.62 - $56.47 $3.59 Million - $4.01 Million
-71,017 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$46.55 - $56.83 $1.27 Million - $1.55 Million
-27,250 Reduced 27.73%
71,017 $3.69 Million
Q2 2021

Aug 16, 2021

BUY
$46.28 - $52.75 $1.53 Million - $1.74 Million
32,996 Added 50.55%
98,267 $4.76 Million
Q1 2021

May 17, 2021

SELL
$46.25 - $56.02 $38,295 - $46,384
-828 Reduced 1.25%
65,271 $3.16 Million
Q4 2020

Feb 12, 2021

BUY
$46.09 - $54.74 $39,499 - $46,912
857 Added 1.31%
66,099 $3.43 Million
Q3 2020

Nov 12, 2020

BUY
$42.51 - $52.42 $552 - $681
13 Added 0.02%
65,242 $3.39 Million
Q2 2020

Aug 14, 2020

BUY
$39.49 - $44.36 $2,408 - $2,705
61 Added 0.09%
65,229 $2.82 Million
Q1 2020

May 13, 2020

SELL
$33.17 - $41.6 $115,298 - $144,601
-3,476 Reduced 5.06%
65,168 $2.62 Million
Q4 2019

Feb 13, 2020

SELL
$25.41 - $43.1 $3.68 Million - $6.24 Million
-144,853 Reduced 67.85%
68,644 $2.35 Million
Q3 2019

Nov 13, 2019

BUY
$32.73 - $40.81 $4.05 Million - $5.06 Million
123,883 Added 138.24%
213,497 $7.04 Million
Q2 2019

Aug 14, 2019

SELL
$35.73 - $41.39 $82,857 - $95,983
-2,319 Reduced 2.52%
89,614 $3.59 Million
Q1 2019

May 15, 2019

BUY
$33.78 - $40.68 $153,699 - $185,094
4,550 Added 5.21%
91,933 $3.69 Million
Q4 2018

Feb 13, 2019

BUY
$32.65 - $37.95 $825,065 - $958,996
25,270 Added 40.68%
87,383 $2.96 Million
Q3 2018

Nov 13, 2018

SELL
$35.99 - $39.39 $31,563 - $34,545
-877 Reduced 1.39%
62,113 $2.32 Million
Q3 2017

Nov 14, 2017

SELL
$31.02 - $32.94 $1.27 Million - $1.35 Million
-40,903 Reduced 39.37%
62,990 $1.98 Million
Q2 2017

Aug 14, 2017

BUY
N/A
103,893
103,893 $3.47 Million

Others Institutions Holding QGEN

About QIAGEN N.V.


  • Ticker QGEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 227,694,000
  • Market Cap $9.85B
  • Description
  • QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...
More about QGEN
Track This Portfolio

Track Amp Capital Investors LTD Portfolio

Follow Amp Capital Investors LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amp Capital Investors LTD, based on Form 13F filings with the SEC.

News

Stay updated on Amp Capital Investors LTD with notifications on news.